20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T64320 | ML251 | Glucokinase , Parasite | |
ML251 is a potent novel nanomolar inhibitor of T. brucei and T. cruzi phosphofructokinase[1]. ML251 inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=0.13 μM). ML251 can be used for the research of parasite[1]... | |||
T8507 | MAC-545496 | Antibacterial | |
MAC-545496 is a glycopeptide-resistance-associated protein R (GraR) inhibitor, is an antivirulence agent. | |||
T6322 | Copanlisib | BAY 80-6946 | Apoptosis , PI3K |
Copanlisib (BAY 80-6946) is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor c... | |||
T14998 | Copanlisib dihydrochloride | BAY 80-6946 dihydrochloride | Apoptosis , PI3K , mTOR |
Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ). Copanlisib dihydrochloride has super... | |||
T6931 | PD0166285 | PD-166285 | Apoptosis , Wee1 , Chk |
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator. | |||
T26600 | Alpidem | Ananxyl | GABA Receptor |
Alpidem (Ananxyl) is an anxiolytic drug from the imidazopyridine family. Alpidem does not produce sedative effects at normal doses, and is instead used specifically for the treatment of anxiety. Alpidem has nanomolar bin... | |||
T24040 | ERDRP-0519 | ERDRP0519,ERDRP 0519 | Antiviral |
ERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase. It effectively prevents measles disease in squirrel monkeys (Saimiri sciureus) and exhibits potent inhibition of morbil... | |||
T2300 | AZD1208 | Apoptosis , Pim , Autophagy | |
AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases. | |||
TQ0019 | RR6 | Others | |
RR6 acts as a selective, reversible, and competitive vanin inhibitor at nanomolar concentration. | |||
T8701 | GRP-60367 | Others | |
GRP-60367 is the first small molecule rabies virus (RABV) entry inhibitor, which has nanomolar effect on some RABV strains. | |||
T8827 | EMAC10101d | Carbonic Anhydrase | |
compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an inhibitory activity in the low nanomolar range. | |||
T16392 | ONC206 | Dopamine Receptor | |
ONC206, an analogue of the TRAIL inducer ONC201, acts as a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations and possesses broad-spectrum anti-tumor activity. | |||
T39039 | FSCPX | Adenosine Receptor | |
FSCPX is a potent and selective irreversible antagonist of the A1 adenosine receptor (A1AR), exhibiting low nanomolar binding potency. Additionally, FSCPX can effectively decrease the interstitial adenosine level in the ... | |||
T3582 | BTZ043 | Antibacterial , Antibiotic , DprE1 | |
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro. | |||
T9295 | BLU-263 | c-Kit | |
BLU-263 is an investigational, potent, and selective oral small molecule inhibitor of KIT with sub-nanomolar potency against D816V-mutant KIT. | |||
T14501 | BAY-2402234 | Dehydrogenase , DNA/RNA Synthesis | |
BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. | |||
T6828 | ZL0420 | Epigenetic Reader Domain | |
ZL0420 is a potent and selective bromodomain-containing protein 4 ( BRD4 ) inhibitor with nanomolar binding affinities to bromodomains (BDs) of BRD4. ZL0420 has IC 50 values of 27 nM against BRD4 BD1 and 32 nM against B... | |||
T37376 | PHY34 | Autophagy | |
PHY34 is a late stage autophagy inhibitor with nanomolar level inhibitory effect and anti-tumor activity against high-grade serous ovarian cancer (HGSOC) in vivo. | |||
T10533 | BI-2852 | Ras | |
BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) with nanomolar affinity. BI-2852 is leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells. | |||
T12328 | OSMI-4 | Others | |
OSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor (EC50 of 3 μM in cells), which can be used to study OGT inhibition in different human cell lines. |